UroGen Pharma Ltd. (FRA:UR8)
Germany · Delayed Price · Currency is EUR 18.40
-0.90 (-4.66%)
At close: Jan 6, 2026
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of €855.13 million as of January 9, 2026. Its market cap has increased by 96.72% in one year.
Market Cap
855.13M
Enterprise Value
857.31M
Revenue
82.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
€18.40
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from 152.95M to 855.13M, an increase of 459.10%. That is a compound annual growth rate of 21.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 855.13M | -8.41% |
| Dec 31, 2025 | 933.69M | 115.09% |
| Dec 31, 2024 | 434.10M | 3.64% |
| Dec 29, 2023 | 418.87M | 118.57% |
| Dec 30, 2022 | 191.64M | 2.22% |
| Dec 31, 2021 | 187.48M | -42.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |